We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

A picture of Sarah Whelan, PhD

Sarah Whelan, PhD profile page

Science Writer

 at Technology Networks

Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.


University of Kent  

University of Leicester  

Areas of Expertise

Got a Question for Sarah Whelan, PhD?

Get in touch using the contact form linked here and we’ll get back to you shortly

Published Content
Total: 281
Image of a blue and red drug capsule showing a chemical structure.

ALS Drug Pulled From Market After Disappointing Trial Results

The amyotrophic lateral sclerosis (ALS) drug Relyvrio has been pulled from US and Canadian markets by its maker, Amylyx Pharmaceuticals, after topline trial data showed it worked no better than a placebo.
A digital image of a brain with multicolored threads emerging from it.

Diabetes Drug Shows Promise for Parkinson’s Disease in Trial

Results from a Phase 2 clinical trial suggest that lixisenatide – a drug used to treat type 2 diabetes – may also slow the progression of Parkinson’s disease symptoms.
Computer-generated image of cells.

Ancient DNA May Uncover Ethnic Differences in Childhood Cancer

Researchers have harnessed ancient DNA to trace a genetic variant – one that increases the risk of a type of childhood cancer – back to the first people who migrated into the Americas approximately 13,000 years ago.
The Genetic Basis of Cancer infographic snippet

The Genetic Basis of Cancer

Cancer is inherently a genetic disease, and advances in our knowledge of the genetic basis of cancer can help to guide earlier diagnosis and improve treatments to benefit patients.
Bioprocessing infographic teaser

The Basics of Bioprocessing

Download this infographic to learn more about what bioprocessing is, the techniques and systems used in bioprocessing, and key considerations, challenges and future trends for the field.
A dropper of CBD oil.

No Evidence That CBD Products Reduce Chronic Pain, Study Finds

A new study has concluded that there is no evidence that cannabidiol (CBD) products reduce chronic pain, suggesting that they are not value for money and even have the potential to harm health.
A collection of many different pills.
Industry Insight

Setting the Stage for Multipurpose Drugs

We spoke with Dr. Bryan Oronsky, chief development officer at EpicentRx, to discover more about the promise of multipurpose drugs and the potential of EpicentRx’s nibrozetone (RRx-001) for several conditions.
Computer-generated image of a DNA double helix.

Gene Editing Can Eliminate HIV From Cell Culture, Researchers Claim

The genome editing tool CRISPR-Cas9 can eliminate HIV viruses from lab-cultured cells, according to not-yet peer-reviewed research to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).
Two glass vials each containing a strand of DNA.

Genetics in Disease

Some genetic diseases, like sickle cell anemia, are hereditary and present at birth. Others can be caused by spontaneous mutations, either arising from errors in DNA replication or exposure to environmental factors.
A person holding pills in their hand next to a dossete box and glass of water.

Metformin Tied to Production of “Anti-Hunger” Molecule

The same “anti-hunger” molecule stimulated by vigorous exercise can also be produced by the common diabetes drug metformin, according to a new study from Stanford University.